Low or intermediate score on Short Physical Performance Battery linked to increased risks for composite, individual CVD outcomes.
In the US, prevalence of CV risk factors and disease set to decrease for Whites and increase for racial/ethnic minorities.
Risk for CVD, heart failure, and stroke significantly increased after adjustment for cardiovascular risk factors.
Researchers conducted a population-based cohort study involving patients with T2D aged 18 years and older initiating treatment with SGLT-2i or metformin.
Sodium-glucose cotransporter-2 inhibitors recommended for HF with reduced, mildly reduced ejection fraction.
Aspirin use was associated with increased risk for incident heart failure among individuals with or without a history of cardiovascular disease
Findings for both out-of-hospital and in-hospital ST-segment elevation myocardial infarction.
46 percent of those diagnosed in acute care had potential heart failure symptoms in previous six months.
Please login or register first to view this content.
